5 Best German Stocks to Buy Now

Page 4 of 4

1. BioNTech SE (NASDAQ:BNTX)

Number of Hedge Fund Holders: 18 

BioNTech SE (NASDAQ:BNTX) is a biotechnology company that develops and commercializes immunotherapies for cancer and other infectious diseases. On November 30, BioNTech revealed that it has signed a collaboration and license agreement for a small molecule program targeting immune modulation in cancer with Poland-based Ryvu.

On November 8, Canaccord analyst William Maughan maintained a Buy rating on BioNTech SE (NASDAQ:BNTX) stock and lowered the price target to $191 from $200, noting that the company’s third-quarter results show steady commercial success and advancing pipeline. 

At the end of the third quarter of 2022, 18 hedge funds in the database of Insider Monkey held stakes worth $186 million in BioNTech SE (NASDAQ:BNTX), compared to 26 in the preceding quarter worth $380.5 million.

You can also take a peek at 15 Best Cybersecurity Stocks To Buy and 25 Smartest Countries in the World.

Page 4 of 4